Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors that are overexpressed on the surface of cancer cells. The radiation is used either for detection (imaging) or for destruction (therapy) of these tumors. The Division of Radiopharmaceutical Chemistry at...
Main Authors: | Rosalba Mansi, Melpomene Fani |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2021-06-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/contentone/scs/chimia/2021/00000075/00000006/art00007 |
Similar Items
-
Radiooznačeni peptidi v nuklearni medicini
by: Marko Krošelj, et al.
Published: (2018-10-01) -
Targeted Radiotherapeutics from 'Bench-to-Bedside'
by: Cristina Müller, et al.
Published: (2020-12-01) -
Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms
by: Melpomeni Fani, et al.
Published: (2017-03-01) -
Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs
by: Taraneh Sadat Zavvar, et al.
Published: (2023-02-01) -
Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
by: Melpomeni Fani, et al.
Published: (2022-02-01)